Use of azithromycin in the treatment of acute exacerbations of COPD.
作者： Aaron Milstone
DOI: 10.2147/COPD.S1189
关键词:
摘要: Chronic bronchitis is a relatively common entity among patients with underlying chronic obstructive lung disease. Typical treatment includes pulmonary hygiene, bronchodilators, and antimicrobial therapy. In recent years, the duration of therapy in acute exacerbations COPD has become shorter shorter. This review summarizes data on use drug azithromycin for this particular patient population focus 3-day single-day
sci-hub.se 参考文章(47)
X A Biebuyck, , Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group. Journal of International Medical Research. ,vol. 24, pp. 407- 418 ,(1996) , 10.1177/030006059602400502
Robert N Swanson, Alberto Lainez-Ventosilla, Maria C De Salvo, Michael W Dunne, Guy W Amsden, Once-Daily Azithromycin for 3 Days Compared with Clarithromycin for 10 Days for Acute Exacerbation of Chronic Bronchitis Treatments in Respiratory Medicine. ,vol. 4, pp. 31- 39 ,(2005) , 10.2165/00151829-200504010-00004
Richard S. Castaldo, Bartolome R. Celli, Fernando Gomez, Nicole LaVallee, Joseph Souhrada, John P. Hanrahan, A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease Clinical Therapeutics. ,vol. 25, pp. 542- 557 ,(2003) , 10.1016/S0149-2918(03)80095-4
Joan B. Soriano, Kourtney J. Davis, Bobbie Coleman, George Visick, David Mannino, Neil B. Pride, The Proportional Venn Diagram of Obstructive Lung Disease*: Two Approximations From the United States and the United Kingdom Chest. ,vol. 124, pp. 474- 481 ,(2003) , 10.1378/CHEST.124.2.474
Warren Whitlock, Multicenter comparison of azithromycin and amoxicillin/clavulanate in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease Current Therapeutic Research-clinical and Experimental. ,vol. 56, pp. 985- 995 ,(1995) , 10.1016/0011-393X(95)85105-4
Sanjay Saint, Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations JAMA. ,vol. 273, pp. 957- 960 ,(1995) , 10.1001/JAMA.1995.03520360071042
Ronald Grossman, Jayanti Mukherjee, David Vaughan, Clive Eastwood, Richard Cook, Jacques LaForge, Noel Lampron, A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis : The Canadian Ciprofloxacin Health Economic Study Group Chest. ,vol. 113, pp. 131- 141 ,(1998) , 10.1378/CHEST.113.1.131
MICHAEL R. JACOBS, Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children The Pediatric Infectious Disease Journal. ,vol. 22, pp. S109- S119 ,(2003) , 10.1097/00006454-200308001-00002
Alicia A Cymbala, Lee C Edmonds, Michael A Bauer, Peter J Jederlinic, John J May, Jennifer M Victory, Guy W Amsden, The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treatments in Respiratory Medicine. ,vol. 4, pp. 117- 122 ,(2005) , 10.2165/00151829-200504020-00005
Marcus Zervos, Jeanne D. Breen, Daniel M. Jorgensen, James M. Goodrich, Novel, single-dose microsphere formulation of azithromycin versus levofloxacin for the treatment of acute exacerbation of chronic bronchitis Infectious Diseases in Clinical Practice. ,vol. 13, pp. 115- 121 ,(2005) , 10.1097/01.IDC.0000161504.41501.E7